Clinical Research
Ascletis' ASC47 Shows Promise in Phase I Trial with Once-Monthly Dosing and Superior Fat Reduction in Obesity Treatment
Data from a Phase I single ascending dose (SAD) study in Australia in subjects with elevated low-density lipoprotein cholesterol (LDL-C) showed...
November 08, 2024 | News
AstraZeneca to Create Over 800 Jobs in Singapore with New $1.5 Billion Facility for Precision Cancer Therapies
AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global su...
November 08, 2024 | News
Powering Up Cartilage: New Mitochondrial Therapy Offers Fresh Hope for Osteoarthritis Patients
Researchers have discovered a promising new method for potentially treating osteoarthritis (OA), a debilitating joint disease for which there are currently...
November 08, 2024 | News
Inocras and Summit Pharmaceuticals Ink MOU to Transform Genomic Medicine in Japan
Inocras Inc. and Summit Pharmaceuticals International Corporation (“SPI”) signed an MOU (Memorandum of understanding) to jointly ex...
November 06, 2024 | News
Ring Therapeutics Partners with Singapore's A*STAR and SERI to Drive R&D in Ophthalmology, Oncology, and Bioprocessing
Wide-ranging A*STAR and SERI partnership will accelerate the development of novel developmental candidates in the areas of ophthalmology and onco...
November 06, 2024 | News
Parse Biosciences Launches Evercode™ Low Input Fixation Kits, Enabling Single Cell Sequencing with Minimal Starting Material
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Ever...
November 05, 2024 | News
Medidata Introduces Oncology and Vaccine Solutions to Streamline Phase II and III Trials with FDA-Aligned Patient-Centric Design
The new products combine Medidata's diverse technologies and experience from thousands of previous trials to streamline the management of Phase II an...
November 05, 2024 | News
Breast Cancer Drug Shows Promise for Treating Hereditary Hemorrhagic Telangiectasia, a Rare Vascular Disorder
A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic ble...
November 05, 2024 | News
Leica Biosystems and Cell Signaling Technology Join Forces to Streamline Spatial Biology Research with SignalStar™ Multiplex IHC on BOND RX
Fully automated SignalStar™ Multiplex IHC protocol on the BOND RX by Leica Biosystems eliminates hands-on time for streamlined image generation ...
November 05, 2024 | News
Wasatch BioLabs and Oxford Nanopore Collaborate on Breakthrough Direct Whole Methylome Sequencing Product
Wasatch Biolabs (WBL), a disruptive R&D and high-throughput clinical laboratory, today announced a collaboration with Oxford Nanopore Technologies (ONT...
November 04, 2024 | News
Chipscreen Biosciences Secures NMPA Approval for Phase III Trial of Chiauranib in ES-SCLC Treatment
Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen Biosciences") and its wholly-owned subsidiary Chengdu Chipscreen Ph...
November 04, 2024 | News
Taiwan’s CStone Secures UK Approval for Sugemalimab as First-Line Treatment for Metastatic NSCLC
This approval marks the second international marketing authorization for sugemalimab outside of China, following its recent approval by the Eur...
November 01, 2024 | News
Hong Kong's Akeso Biopharma Advances Immunotherapy in Biliary Tract Cancer with First Patient Enrolled in Phase III Study of Ivonescimab
Akeso Biopharma (9926.HK) is pleased to announce the successful enrollment of the first patient in the HARMONi-GI-01/AK112-309 study, a randomized, c...
November 01, 2024 | News
Australia's Telix Pharmaceuticals Partners with Subtle Medical for AI-Powered PET Imaging, Enhancing Illuccix® Efficiency and Patient Experience
Telix Pharmaceuticals announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powere...
October 31, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
